調査レポートカテゴリー： IT/電子, MarketsandMarkets, 世界

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

臨床試験電子化ソリューション（eClinical）の世界市場予測（～2022年）

◆タイトル：eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022
◆商品コード：MAM-HIT2208
◆調査・発行会社：MarketsandMarkets
◆発行日：2017年4月19日
◆ページ数：167
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：IT
◆販売価格オプション（消費税別）

Single User（1名利用）	USD5,650 ⇒換算￥615,850	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥724,850	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥888,350	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、臨床試験電子化ソリューション（eClinical）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別分析、導入方式別分析、治験段階別分析、需要先別分析、臨床試験電子化ソリューション（eClinical）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.
On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region.

Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2016. Partnerships, agreements, and collaborations; product launches, enhancements, and deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most players to achieve growth in the eClinical solutions market.

Research Coverage:
The report covers software solutions used across all phases in the clinical trial process. It aims at estimating the market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions. The report also includes an in-depth competitive analysis of the key players with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:
This report focuses on various levels of analysis—market share analysis of the top players and company profiles, which discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner greater market shares. Companies purchasing the report could use any one of the combination of the strategies mentioned below, namely, market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the market. The report analyzes the eClinical solutions market, by product, delivery mode, clinical trial phase, and end users across four geographies.

• Product Development/Innovation: Detailed insights on current technologies, research and development activities, and product launches in the eClinical solutions market.

• Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).

• Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 MAJOR MARKET STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY DATA 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Key data from primary sources 22
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 23
2.2.1.1 Bottom-up approach 25
2.2.1.2 Top-down approach 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 RESEARCH ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 34
4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW 34
4.2 ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 VS. 2015 VS. 2022 (USD MILLION) 35
4.3 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016) 36
4.4 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017 VS. 2022) 37
4.5 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017–2022) 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 MAJOR MARKET DRIVERS 39
5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies 39
5.2.1.2 Growing adoption of novel software solutions in clinical research 39
5.2.1.3 Rising government funding & grants to support clinical trials 40
5.2.1.4 Growing adoption of eClinical solutions for improved data standardization 41
5.2.1.5 Increasing R&D expenditure by pharma-biotech companies with augmented IT expenditure allocations for drug development pipeline 41
5.2.1.6 Growing customer base for eClinical solutions 42
5.2.2 MAJOR MARKET RESTRAINTS 43
5.2.2.1 High implementation costs associated with eClinical solutions 43
5.2.2.2 Dearth of skilled professionals for operating eClinical solutions 43
5.2.2.3 Limited awareness among researchers related to advantages of eClinical solutions 43
5.2.3 KEY GROWTH OPPORTUNITIES 43
5.2.3.1 Increasing clinical research activities in emerging Asian countries 43
5.2.3.2 Increased outsourcing of clinical trial processes by industrial researchers to CROs 44
5.2.3.3 Rising number of clinical trials, especially across emerging countries 44
5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies 44
5.2.4 MAJOR MARKET CHALLENGES 45
5.2.4.1 Limited adoption of eClinical solutions in developing nations 45
5.2.4.2 Software reliability 45
5.2.4.3 Patient privacy 45

6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 46
6.1 INTRODUCTION 47
6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 48
6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS 50
6.4 CLINICAL ANALYTICS PLATFORMS 52
6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 54
6.6 CLINICAL DATA INTEGRATION PLATFORMS 56
6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 57
6.8 SAFETY SOLUTIONS 59
6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS 60
6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 61
6.11 OTHER ECLINICAL SOLUTIONS 62

7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 63
7.1 INTRODUCTION 64
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 65
7.3 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 66
7.4 CLOUD-BASED (SAAS) SOLUTIONS 67

8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 69
8.1 INTRODUCTION 70
8.2 PHASE I CLINICAL TRIALS 71
8.3 PHASE II CLINICAL TRIALS 72
8.4 PHASE III CLINICAL TRIALS 73
8.5 PHASE IV CLINICAL TRIALS 75

9 ECLINICAL SOLUTIONS MARKET, BY END USER 76
9.1 INTRODUCTION 77
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 78
9.3 CONTRACT RESEARCH ORGANIZATIONS 79
9.4 CONSULTING SERVICE COMPANIES 81
9.5 MEDICAL DEVICE MANUFACTURERS 82
9.6 HOSPITALS 83
9.7 ACADEMIC RESEARCH INSTITUTES 84

10 ECLINICAL SOLUTIONS MARKET, BY REGION 85
10.1 INTRODUCTION 86
10.2 NORTH AMERICA 87
10.2.1 U.S. 91
10.2.2 CANADA 93
10.3 EUROPE 95
10.4 ASIA-PACIFIC 102
10.5 REST OF THE WORLD 106

11 COMPETITIVE LANDSCAPE 110
11.1 OVERVIEW 110
11.2 MARKET SHARE ANALYSIS 110
11.3 COMPETITIVE SITUATION AND TRENDS 112
11.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 112
11.3.2 PRODUCT DEPLOYMENTS 113
11.3.3 PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS 113
11.3.4 MERGERS & ACQUISITIONS 114
11.3.5 EXPANSIONS 115
11.3.6 OTHER STRATEGIES 116

12 COMPANY PROFILES 117
12.1 INTRODUCTION 117
(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*
12.2 ORACLE CORPORATION 118
12.3 MEDIDATA SOLUTIONS, INC. 124
12.4 PAREXEL INTERNATIONAL CORPORATION 130
12.5 BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN) 134
12.6 DATATRAK INTERNATIONAL, INC. 137
12.7 CRF HEALTH 140
12.8 ERT CLINICAL 142
12.9 MERGE HEALTHCARE INCORPORATED 144
12.10 OMNICOMM SYSTEMS, INC. 146
12.11 MAXISIT INC. 151
12.12 BIO-OPTRONICS, INC. 152
12.13 ECLINICAL SOLUTIONS, LLC. 154
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 155
13.1 DISCUSSION GUIDE* 155
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 159
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 161
13.4 AVAILABLE CUSTOMIZATIONS 162
13.5 RELATED REPORTS 163

LIST OF TABLES

TABLE 1 U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN
2011 & 2015 42
TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 48
TABLE 3 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 49
TABLE 4 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 50
TABLE 5 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 6 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2015–2022 (USD MILLION) 52
TABLE 7 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 53
TABLE 8 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 54
TABLE 9 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 10 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 11 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 57
TABLE 12 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY COUNTRY, 2015–2022 (USD MILLION) 57
TABLE 13 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 58
TABLE 14 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 58
TABLE 15 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 59
TABLE 16 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2022 (USD MILLION) 59
TABLE 17 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 18 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 19 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 20 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 21 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 62
TABLE 22 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 23 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY,
2015–2022 (USD MILLION) 65
TABLE 24 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 65
TABLE 25 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 66
TABLE 26 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 68
TABLE 27 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 70
TABLE 28 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 71
TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 72
TABLE 30 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 73
TABLE 31 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 73
TABLE 32 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 33 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 74
TABLE 34 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015–2022 (USD MILLION) 75
TABLE 35 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015–2022 (USD MILLION) 75
TABLE 36 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 77
TABLE 37 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION) 79
TABLE 38 KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES
(2011–2015) 80
TABLE 39 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2015–2022 (USD MILLION) 80
TABLE 40 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES,
BY REGION, 2015–2022 (USD MILLION) 81
TABLE 41 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS,
BY REGION, 2015–2022 (USD MILLION) 82
TABLE 42 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2015–2022 (USD MILLION) 83
TABLE 43 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES,
BY REGION, 2015–2022 (USD MILLION) 84
TABLE 44 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2022 (USD MILLION) 87
TABLE 45 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015-2022 (USD MILLION) 89
TABLE 46 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 89
TABLE 47 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 90
TABLE 48 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 90
TABLE 49 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015-2022 (USD MILLION) 91
TABLE 50 U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 92
TABLE 51 U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015-2022 (USD MILLION) 93
TABLE 52 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015-2022 (USD MILLION) 94
TABLE 53 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015-2022 (USD MILLION) 94
TABLE 54 EMA-APPROVED BIOSIMILARS 96
TABLE 55 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 100
TABLE 56 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 100
TABLE 57 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 101
TABLE 58 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 101
TABLE 59 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 104
TABLE 60 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 104
TABLE 61 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2022 (USD MILLION) 105
TABLE 62 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 105
TABLE 63 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2022 (USD MILLION) 107
TABLE 64 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2022 (USD MILLION) 108
TABLE 65 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2022 (USD MILLION) 108
TABLE 66 ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2022 (USD MILLION) 109
TABLE 67 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013–2017) 112
TABLE 68 PRODUCT DEPLOYMENTS (2013–2017) 113
TABLE 69 PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013–2017) 114
TABLE 70 MERGERS & ACQUISITIONS (2013–2017) 114
TABLE 71 EXPANSIONS (2013–2017) 115
TABLE 72 OTHER STRATEGIES (2013–2017) 116

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 19
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
FIGURE 3 ECLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH 24
FIGURE 4 ECLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH 25
FIGURE 5 ECLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH 26
FIGURE 6 ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION 27
FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2017 VS. 2022 (USD MILLION) 30
FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2017 VS. 2022 (USD MILLION) 31
FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2017 VS. 2022 (USD MILLION) 31
FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2017 VS. 2022 (USD MILLION) 32
FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2016 (USD MILLION) 33
FIGURE 12 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 34
FIGURE 13 EDC & CDMS SEGMENT TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2022 35
FIGURE 14 WEB-HOSTED DELIVERY MODE DOMINATED THE ECLINICAL SOLUTIONS MARKET ACROSS ALL REGIONAL SEGMENTS IN 2016 36
FIGURE 15 PHASE III CLINICAL TRIALS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET DURING THE FORECAST PERIOD 37
FIGURE 16 CONTRACT RESEARCH ORGANIZATIONS SEGMENT IN ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE 37
FIGURE 17 GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 18 EDC AND CDMS SEGMENT DOMINATED THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 47
FIGURE 19 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR EDC AND CDMS SOLUTIONS MARKET IN 2017 49
FIGURE 20 ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR CTMS MARKET DURING 2017-2022 51
FIGURE 21 NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR CLINICAL ANALYTICS PLATFORMS MARKET IN 2017 53
FIGURE 22 ASIA-PACIFIC IS PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR RTSM SOLUTIONS MARKET TILL 2022 55
FIGURE 23 WEB-HOSTED SOLUTIONS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 64
FIGURE 24 PHASE III TRIALS TO WITNESS HIGHEST DEMAND GROWTH FOR ECLINICAL SOLUTIONS DURING THE FORECAST PERIOD 70
FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2016) 77
FIGURE 26 R&D EXPENDITURE OF TOP 8 PHARMACEUTICAL COMPANIES,
2013 VS. 2015 (USD MILLION) 78
FIGURE 27 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2017 VS. 2022 (USD MILLION) 86
FIGURE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT 88
FIGURE 29 EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT 95
FIGURE 30 EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012) 99
FIGURE 31 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT 102
FIGURE 32 ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT 106
FIGURE 33 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2016 110
FIGURE 34 GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS (2015)* 117
FIGURE 35 ORACLE CORPORATION: COMPANY SNAPSHOT (2016) 118
FIGURE 36 MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT (2015) 124
FIGURE 37 PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT (2016) 130
FIGURE 38 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 137
FIGURE 39 MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT (2014) 144
FIGURE 40 OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT (2015) 146

【レポートのキーワード】

臨床試験電子化ソリューション

★調査レポート[臨床試験電子化ソリューション（eClinical）の世界市場予測（～2022年）] ( eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022 / MAM-HIT2208) 販売に関する免責事項

[臨床試験電子化ソリューション（eClinical）の世界市場予測（～2022年）] ( eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022 / MAM-HIT2208) についてEメールでお問い合わせ

◆関連調査資料◆

コンピュータ支援コーディング（CAC）の世界市場予測（～2022年）
MAM-HIT3168 / MarketsandMarkets / 2017年7月13日 / 当調査レポートでは、コンピュータ支援コーディング（CAC）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、ソフトウェア別分析、サービス別分析、用途別分析、地域別分析、コンピュータ支援コーディング（CAC）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global computer-assisted coding market is projected to reach USD 4.75 Billion by 2022 at a CAGR of 11.5% during the forecast period. The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the rising demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures. However, high implementation and maintenance expenses for computer-assisted coding and lack of IT professionals in the healthcare industry are likely to hinder the growth of the market to...

コンパニオン診断（CDx）の世界市場予測（～2022年）
MAM-MD5463 / MarketsandMarkets / 2017年8月1日 / 当調査レポートでは、コンパニオン診断（CDx）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、技術別分析、疾患別分析、需要先別分析、地域別分析、コンパニオン診断（CDx）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global market is projected to reach USD 6.51 Billion by 2022 from USD 2.61 Billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. The report analyzes the companion diagnostics market by product & service, technology, indication, end user, and region. On the basis of product & service, the assay kits & reagents segment accounted for the largest share in 2016, owing to...

Webアプリケーションファイアウォール（WAF）の世界市場予測（～2022年）
TC-5621 / MarketsandMarkets / 2017年10月4日 / MarketsandMarketsが発行した当調査レポートでは、Webアプリケーションファイアウォール（WAF）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、ソリューション別分析、サービス別分析、企業規模別分析、地域別分析、Webアプリケーションファイアウォール（WAF）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The Web Application Firewall (WAF) market is expected to grow at a Compound Annual Growth Rate (CAGR) of 18.3% during the forecast period, due to the rise in instances of targeted attacks on web applicationsThe global WAF market size is expected to grow from USD 2.37 billion in 2017 to USD 5.48 billion by 2022, at a CAGR of 18.3%. Increasing competitiveness, in the current scenario of the business environment, has made it crucial for organizations to have web applications devoted to the cause of the organization. Furthermore, with the emergence and increasing penetration of iOS and Android-based smartphones, businesses...

デジタルフォレンジック（法科学）の世界市場予測（～2022年）：構想要素、種類、ツール、産業、地域別分析
TC-3619 / MarketsandMarkets / 2018年3月6日 / MarketsandMarketsが発行した当調査レポートでは、デジタルフォレンジック（法科学）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、構成要素別分析、種類別分析、産業別分析、地域別分析、デジタルフォレンジック（法科学）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...Stringent regulatory compliances and the exponential increase in cybercrimes are expected to drive the digital forensics marketThe digital forensics market size is expected to grow from USD 4.62 billion in 2017 to USD 9.68 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 15.9% during the forecast period. The market is expected to be driven by factors, such as the increasing instances of cyber-attacks on enterprise devices, massive use of Internet of Things (IoT) devices, and stringent regulations. However, encryption is expected to be a major hindrance for enterprises to adopt the digital forensic components. . Cloud forensics...

持続的腎代替療法 (CRRT) の世界市場予測（～2022年）：装置、血液ろ過器、血液用ライン、透析液
MAM-MD3842 / MarketsandMarkets / 2017年7月20日 / 当調査レポートでは、持続的腎代替療法 (CRRT) の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、市場環境分析、製品別分析、モード別分析、処置別分析、地域別分析、持続的腎代替療法 (CRRT) の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global CRRT market is projected to reach USD 1.53 Billion by 2022 from USD 1.09 Billion in 2017, at a CAGR of 7.0%. Growing number of ICU patients, increasing incidence of sepsis, rising incidence of acute kidney injuries, technological advancements, and clinical advantages of CRRT over intermittent blood purification techniques are some of the key factors driving the growth of the market. This CRRT market is segmented based on product, and modality. On the basis of product, the CRRT market is segmented into CRRT systems, disposables, and dialysates & replacement fluids, in which dialysates and replacement fluids is expected...

人財管理（HCM）の世界市場予測（～2022年）
MAM-TC3207 / MarketsandMarkets / 2017年6月30日 / 当調査レポートでは、人財管理（HCM）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、ソフトウェア別分析、サービス別分析、導入方式別分析、地域別分析、人財管理（HCM）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The Human Capital Management (HCM) market is expected to grow from USD 14.50 Billion in 2017 to USD 22.51 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 9.2%, because of the increasing complexities in managing the widespread workforce. Moreover, acquiring the right talent is another major factor contributing to the growth of Human Capital Management market. The HCM solutions offers different software, such as core Human Resources (HR), workforce management, sourcing and recruiting, applicant tracking system, and staffing vendor management. In software, sourcing and recruiting, and workforce management segment are expected to have significant market growth rates...

モジュールUPS（無停電電源装置）の世界市場予測（～2022年）
MAM-TC-3668 / MarketsandMarkets / 2017年12月19日 / MarketsandMarketsが発行した当調査レポートでは、モジュールUPS（無停電電源装置）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソリューション別分析、サービス別分析、企業規模別分析、産業別分析、モジュールUPS（無停電電源装置）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Factors such surging demand for colocation facilities, reduced total cost of ownership, scalability functionality, and simplified installation and integration of new modules are some of the factors driving the modular UPS market growth.” The modular UPS market size is expected to grow from USD 966.0 million in 2017 to USD 1,741.9 million by 2022, at a Compound Annual Growth Rate (CAGR) of 12.5% during the forecast period. The market growth is driven by various factors, such as the need for faster deployment of solutions and scalability, increasing awareness about the modular UPS systems among enterprises globally, and reduced total cost...

重要インフラストラクチャ保護（CIP）の世界市場予測（～2022年）
MAM-TC3249 / MarketsandMarkets / 2017年7月26日 / 当調査レポートでは、重要インフラストラクチャ保護（CIP）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、セキュリティ技術別分析、サービス別分析、産業別分析、地域別分析、重要インフラストラクチャ保護（CIP）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Rise in security breaches and cyber-attacks targeting enterprises across various industry verticals is expected to drive the Critical Infrastructure Protection (CIP) market”The CIP market size is estimated to grow from USD 110.41 billion in 2017 to USD 153.16 billion by 2022, at an estimated Compound Annual Growth Rate (CAGR) of 6.8%. The CIP market includes various security technologies, which are essential for safeguarding critical assets, enterprises, and territories from physical and cyber-attacks. Increased instances of physical attacks, such as terrorist activities, thefts, and intrusion drones, and cyber-attacks which include malware, ransomware, virus, and Advanced Persistent Threats (APTs) have driven the...

デジタルPCR及びリアルタイムPCR（qPCR）の世界市場予測（～2022年）：装置、試薬
MAM-BT3161 / MarketsandMarkets / 2017年6月27日 / 当調査レポートでは、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、バリューチェーン分析、市場シェア分析、市場環境分析、技術別分析、製品別分析、用途別分析、需要先別分析、デジタルPCR及びリアルタイムPCR（qPCR）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global dPCR and qPCR market is expected to reach USD 5.31 Billion by 2022, growing at a CAGR of 8.9% during 2017-2022. Factors such as the growth in the geriatric population, rising incidence of infectious diseases and genetic disorders, technological advancements in the field of PCR, and increasing investments and availability of funds for PCR-based research are driving the growth of the global dPCR and qPCR market. However, factors such as high cost of dPCR products and technical limitations associated with qPCR and dPCR are restraining the growth of this market. In addition to this, adoption and implementation of...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆